Bitcoin price today: rises to $116.5k on Trump 401k order, altcoins rally
LONDON - Montagu Private Equity LLP has announced that it no longer intends to make an offer to acquire Advanced Medical (TASE:BLWV) Solutions Group plc ( AMS (VIE:AMS2)), a decision revealed on Thursday. The private equity firm had previously indicated on March 27, 2025, that it was considering a bid for the medical technology company.
In compliance with the City Code on Takeovers and Mergers, specifically under Rule 2.8, Montagu is now restricted from proposing an offer for AMS, barring certain conditions. These exceptions include obtaining consent from AMS’s board of directors, the emergence of a third-party offer for AMS, a proposal from AMS that would lead to a waiver under Rule 9, or a reverse takeover. Additionally, Montagu could revisit its position if the Takeover Panel acknowledges a significant change in circumstances.
The announcement concludes a period of speculation regarding the potential acquisition of AMS by funds managed or advised by Montagu. The news may impact AMS’s share price and market expectations, as investors had been monitoring the situation closely since the initial expression of interest last month.
Montagu’s decision to step back from the transaction is binding unless one of the outlined scenarios occurs, providing a clear end to the current takeover talks. This development is based on a press release statement and is part of the factual information surrounding the transaction discussions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.